Federal grants to Tavo Biotherapeutics, Inc
Tavo Biotherapeutics, Inc in Memphis, Tennessee received $2.9 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Vision Research, with $2.9 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.9 million
- Awards3
- Awarded in FY 2025$1.0 million
- Largest award$2.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $356,501 |
| FY 2022 | 0 | $0 |
| FY 2023 | 1 | $336,047 |
| FY 2024 | 2 | $1.2 million |
| FY 2025 | 1 | $1.0 million |
Programs that fund Tavo Biotherapeutics, Inc
| Program | Awards | Amount |
|---|---|---|
| Vision Research | 3 | $2.9 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Late-stage pre-clinical development and gmp production of a first-in-class extended release iop-lowering formulation - glaucoma is a multifactorial, polygenetic disease that is the leading cause of irreversible blindness worldwide. Trends predict that by 2040, ~112 million people worldwide will have | Vision Research | August 29, 2024 | $2.1 million |
| Development of a novel depot delivery system for a glaucoma therapeutic - glaucoma is the leading cause of irreversible blindness in the world. Because elevated intraocular pressure (IOP) and iop fluctuations are the primary risk factors for loss of visual field, the current standard of care for adu | Vision Research | August 31, 2023 | $474,656 |
| Neuroprotective properties of a novel glaucoma drug and formulation - glaucoma, the leading cause of irreversible blindness in the world; currently affects more than 3 million in the U.S. And is projected to increase to ~6.3 million by 2050. The four major types of adult-onset glaucoma all lead to v | Vision Research | May 24, 2021 | $356,501 |
Questions people ask
How much federal grant money does Tavo Biotherapeutics, Inc get?
$2.9 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Tavo Biotherapeutics, Inc the most?
The Department of Health and Human Services, with $2.9 million in 3 awards.
What is Tavo Biotherapeutics, Inc's largest federal grant?
$2.1 million under Vision Research, with its first action in the period on August 29, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Memphis
- St Jude Children's Research Hospital Inc
- University of Tennessee
- Memphis-Shelby County Airport Authority
- Memphis Area Transit Authority
- University of Memphis
- City of Memphis, Tennessee
- Shelby County Board of Education
- Shelby County Government
Largest federal grant recipients in Tennessee · Federal grants in Tennessee